Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
Add more filters










Publication year range
1.
J Virol ; 83(19): 9813-23, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19625392

ABSTRACT

Intramuscular inoculation of rhesus macaques with one or more doses of recombinant vesicular stomatitis virus (rVSV) expressing human immunodeficiency virus type 1 (HIV-1) Gag (rVSVgag) typically elicits peak cellular immune responses of 500 to 1,000 gamma interferon (IFN-gamma) enzyme-linked immunospots (ELISPOTS)/10(6) peripheral blood lymphocytes (PBL). Here, we describe the generation of a novel recombinant mumps virus (rMuV) expressing HIV-1 Gag (rMuVgag) and measure the Gag-specific cellular immune responses detected in rhesus macaques following vaccination with a highly attenuated form of rVSV expressing HIV-1 Gag (rVSVN4CT1gag1) and rMuVgag in various prime-boost combinations. Notably, peak Gag-specific cellular immune responses of 3,000 to 3,500 ELISPOTS/10(6) PBL were detected in macaques that were primed with rMuVgag and boosted with rVSVN4CT1gag1. Lower peak cellular immune responses were detected in macaques that were primed with rVSVN4CT1gag1 and boosted with rMuVgag, although longer-term gag-specific responses appeared to remain higher in this group of macaques. These findings indicate that rMuVgag may significantly enhance Gag-specific cellular immune responses when administered with rVSVN4CT1gag1 in heterologous prime-boost regimens.


Subject(s)
Gene Products, gag/metabolism , HIV-1/metabolism , Immunization, Secondary , Mumps virus/metabolism , Vesiculovirus/metabolism , Animals , Chlorocebus aethiops , Cricetinae , Immune System , Interferon-gamma/metabolism , Lymphocytes/virology , Macaca mulatta , Models, Genetic , Vaccination , Vero Cells
2.
Curr Top Microbiol Immunol ; 329: 129-62, 2009.
Article in English | MEDLINE | ID: mdl-19198565

ABSTRACT

An overview is given on the development of technologies to allow reverse genetics of RNA viruses, i.e., the rescue of viruses from cDNA, with emphasis on nonsegmented negative-strand RNA viruses (Mononegavirales), as exemplified for measles virus (MV). Primarily, these technologies allowed site-directed mutagenesis, enabling important insights into a variety of aspects of the biology of these viruses. Concomitantly, foreign coding sequences were inserted to (a) allow localization of virus replication in vivo through marker gene expression, (b) develop candidate multivalent vaccines against measles and other pathogens, and (c) create candidate oncolytic viruses. The vector use of these viruses was experimentally encouraged by the pronounced genetic stability of the recombinants unexpected for RNA viruses, and by the high load of insertable genetic material, in excess of 6 kb. The known assets, such as the small genome size of the vector in comparison to DNA viruses proposed as vectors, the extensive clinical experience of attenuated MV as vaccine with a proven record of high safety and efficacy, and the low production cost per vaccination dose are thus favorably complemented.


Subject(s)
Genetic Engineering , Measles Vaccine/immunology , Measles virus/genetics , Measles/immunology , Animals , Genome, Viral , Humans , Measles/prevention & control , Measles/virology , Measles Vaccine/administration & dosage , Measles Vaccine/genetics , Measles virus/immunology , Mutagenesis, Site-Directed , Vaccines, Combined/administration & dosage , Vaccines, Combined/genetics , Vaccines, Combined/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology
3.
J Virol ; 75(2): 910-20, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11134304

ABSTRACT

Protein-encoding nucleotide sequences of the N, P, M, F, H, and L genes were determined for a low-passage isolate of the Edmonston wild-type (wt) measles virus and five Edmonston-derived vaccine virus strains, including AIK-C, Moraten, Schwarz, Rubeovax, and Zagreb. Comparative analysis demonstrated a high degree of nucleotide sequence homology; vaccine viruses differed at most by 0. 3% from the Edmonston wt strain. Deduced amino acid sequences predicted substitutions in all viral polypetides. Eight amino acid coding changes were common to all vaccine viruses; an additional two were conserved in all vaccine strains except Zagreb. Comparisons made between vaccine strains indicated that commercial vaccine lots of Moraten and Schwarz had identical coding regions and were closely related to Rubeovax, while AIK-C and Zagreb diverged from the Edmonston wt along slightly different paths. These comparisons also revealed amino acid coding substitutions in Moraten and Schwarz that were absent from the closely related reactogenic Rubeovax strain. All of the vaccine viruses contained amino acid coding changes in the core components of the virus-encoded transcription and replication apparatus. This observation, combined with identification of noncoding region nucleotide changes in potential cis-acting sequences of the vaccine strains (C. L. Parks, R. A. Lerch, P. Walpita, H.-P. Wang, M. S. Sidhu, and S. A. Udem, J. Virol. 75:921-933, 2001), suggest that modulation of transcription and replication plays an important role in attenuation.


Subject(s)
Genome, Viral , Measles virus/genetics , Viral Proteins/chemistry , Viral Proteins/genetics , Amino Acid Sequence , Amino Acid Substitution , Animals , Genes, Viral , Humans , Measles Vaccine , Measles virus/chemistry , Measles virus/classification , Measles virus/pathogenicity , Molecular Sequence Data , Mutation , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Vaccines, Attenuated
4.
J Virol ; 75(2): 921-33, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11134305

ABSTRACT

The noncoding sequence of five Edmonston vaccine viruses (AIK-C, Moraten, Rubeovax, Schwarz, and Zagreb) and those of a low-passage Edmonston wild-type (wt) measles virus have been determined and compared. Twenty-one nucleotide positions were identified at which Edmonston wt and one or more vaccine strains differed. The location of some of these nucleotide substitutions suggests that they may influence the efficiency of mRNA synthesis, processing, and translation, as well as genome replication and encapsidation. Five nucleotide substitutions were conserved in all of the vaccine strains. Two of these were in the genomic 3'-terminal transcriptional control region and could affect RNA synthesis or encapsidation. Three were found within the 5'-untranslated region of the F mRNA, potentially altering translation control sequences. The remaining vaccine virus base changes were found in one to four vaccine strains. Their genomic localization suggests that some may modify cis-acting regulatory domains, including the Kozak consensus element of the P and M genes, the F gene-end signal, and the F mRNA 5'-untranslated sequence.


Subject(s)
Genome, Viral , Measles Vaccine , Measles virus/genetics , RNA, Untranslated/analysis , 5' Untranslated Regions/genetics , Base Sequence , DNA, Intergenic , Gene Expression Regulation, Viral , Genes, Regulator , Humans , Measles/virology , Molecular Sequence Data , Sequence Analysis, DNA , Transcription, Genetic , Viral Proteins/genetics
5.
J Mol Biol ; 304(5): 861-71, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11124032

ABSTRACT

During the maturation of rotaviral particles, non-structural protein 4 (NSP4) plays a critical role in the translocation of the immature capsid into the lumen of the endoplasmic reticulum. Full-length NSP4 and a 22 amino acid peptide (NSP4(114-135)) derived from this protein have been shown to induce diarrhea in young mice in an age-dependent manner, and may therefore be the agent responsible for rotavirally-induced symptoms. We have determined the crystal structure of the oligomerization domain of NSP4 which spans residues 95 to 137 (NSP4(95-137)). NSP4(95-137) self-associates into a parallel, tetrameric coiled-coil, with the hydrophobic core interrupted by three polar layers occupying a and d-heptad positions. Side-chains from two consecutive polar layers, consisting of four Gln123 and two of the four Glu120 residues, coordinate a divalent cation. Two independent structures built from MAD-phased data indicated the presence of a strontium and calcium ion bound at this site, respectively. This metal-binding site appears to play an important role in stabilizing the homo-tetramer, which has implications for the engagement of NSP4 as an enterotoxin.


Subject(s)
Glycoproteins/chemistry , Glycoproteins/metabolism , Metals/metabolism , Rotavirus/chemistry , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Binding Sites , Calcium/metabolism , Crystallography, X-Ray , Hydrogen Bonding , Magnesium/metabolism , Models, Molecular , Molecular Sequence Data , Protein Structure, Quaternary , Protein Structure, Tertiary , Sequence Alignment , Strontium/metabolism , Toxins, Biological , Water/metabolism
6.
J Infect Dis ; 182(5): 1331-42, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11010838

ABSTRACT

A live-attenuated, intranasal respiratory syncytial virus (RSV) candidate vaccine, cpts-248/404, was tested in phase 1 trials in 114 children, including 37 1-2-month-old infants-a target age for RSV vaccines. The cpts-248/404 vaccine was infectious at 104 and 105 plaque-forming units in RSV-naive children and was broadly immunogenic in children >6 months old. Serum and nasal antibody responses in 1-2 month olds were restricted to IgA, had a dominant response to RSV G protein, and had no increase in neutralizing activity. Nevertheless, there was restricted virus shedding on challenge with a second vaccine dose and preliminary evidence for protection from symptomatic disease on natural reexposure. The cpts-248/404 vaccine candidate did not cause fever or lower respiratory tract illness. In the youngest infants, however, cpts-248/404 was unacceptable because of upper respiratory tract congestion associated with peak virus recovery. A live attenuated RSV vaccine for the youngest infant will use cpts-248/404 modified by additional attenuating mutations.


Subject(s)
Respiratory Syncytial Viruses/immunology , Viral Vaccines/immunology , Antibodies, Viral/blood , Breast Feeding , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Humans , Immunization , Immunoglobulin A/blood , Infant , Temperature , Vaccines, Attenuated/immunology , Virus Shedding
7.
J Virol ; 74(10): 4831-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10775622

ABSTRACT

A complete DNA copy of the genome of a Jeryl Lynn strain of mumps virus (15,384 nucleotides) was assembled from cDNA fragments such that an exact antigenome RNA could be generated following transcription by T7 RNA polymerase and cleavage by hepatitis delta virus ribozyme. The plasmid containing the genome sequence, together with support plasmids which express mumps virus NP, P, and L proteins under control of the T7 RNA polymerase promoter, were transfected into A549 cells previously infected with recombinant vaccinia virus (MVA-T7) that expressed T7 RNA polymerase. Rescue of infectious virus from the genome cDNA was demonstrated by amplification of mumps virus from transfected-cell cultures and by subsequent consensus sequencing of reverse transcription-PCR products generated from infected-cell RNA to verify the presence of specific nucleotide tags introduced into the genome cDNA clone. The only coding change (position 8502, A to G) in the cDNA clone relative to the consensus sequence of the Jeryl Lynn plaque isolate from which it was derived, resulting in a lysine-to-arginine substitution at amino acid 22 of the L protein, did not prevent rescue of mumps virus, even though an amino acid alignment for the L proteins of paramyxoviruses indicates that lysine is highly conserved at that position. This system may provide the basis of a safe and effective virus vector for the in vivo expression of immunologically and biologically active proteins, peptides, and RNAs.


Subject(s)
DNA, Complementary/genetics , DNA, Complementary/metabolism , Mumps virus/genetics , Mumps/virology , Animals , Base Sequence , Cell Line , Chick Embryo , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Genes, Reporter , Molecular Sequence Data , Mumps virus/growth & development , Mumps virus/metabolism , Nucleoproteins/genetics , Phosphoproteins/genetics , Plasmids , Replicon/genetics , Transfection
8.
Virus Res ; 66(2): 117-22, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10725544

ABSTRACT

Recent studies demonstrate that the rotavirus nonstructural protein NSP4 functions as an enterotoxin and plays an important role in viral pathogenesis. Previous in vitro studies of NSP4 have used a cDNA clone of gene 10 derived from the prototypic rotavirus strain, SA11. We recently compared the sequence of the commonly used NSP4 cDNA with the sequence obtained from several SA11 isolates by direct sequencing of reverse transcription polymerase chain reaction products. One codon difference was identified between the cDNA clone and the SA11 virus isolates, and this resulted in a predicted amino acid substitution at position 47. The cDNA sequence specifies an asparagine at position 47, and the SA11 virus gene 10 encodes a hisitidine. To determine if this amino acid substitution altered the function of NSP4, we analyzed the ability of both NSP4-Asn47 and NSP4-His47 to regulate intracellular calcium levels and exhibit cell cytotoxicity. Our results indicate that the expression of NSP4-His47 from a recombinant baculovirus displays enhanced cytotoxicity and calcium flux.


Subject(s)
DNA-Directed RNA Polymerases , Rotavirus/genetics , Viral Nonstructural Proteins/genetics , Amino Acid Substitution , Asparagine/chemistry , Baculoviridae/genetics , Blotting, Western , Calcium/metabolism , Cell Line , Codon , DNA, Complementary/analysis , Histidine/chemistry , Recombinant Proteins/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Rotavirus/chemistry , Viral Nonstructural Proteins/biosynthesis , Viral Nonstructural Proteins/chemistry
9.
Trop Anim Health Prod ; 31(2): 75-81, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10371006

ABSTRACT

One hundred 6-week-old susceptible cockerels were inoculated with a pathogenic strain of infectious bursal disease virus (IBDV) and kept in the same pen as 100 each of 6-week-old pullets, local chickens and broilers. The cockerels developed depression and diarrhoea on day 3 post inoculation (PI) and most of the pullets and some of the local chickens and broilers showed similar signs on day 4 PI. Loss in weight was severe and similar in the pullets and local chickens, being significantly greater than that in the broilers from days 3-11 PI. The total mortality was 85%, 66.7%, 30% and 20% for the pullets, cockerels, local chickens and broilers, respectively. The lesions were more severe in the pullets and local chickens than in the broilers. IBDV antigen and antibody were detected, respectively, in all the bursal and serum samples from the infected chickens tested. The contact exposure method used in this study simulates better what happens in nature than inoculation with IBDV. The reduced mortality observed among the local chickens, compared with that (61.5%) seen in earlier studies using intraocular inoculation of IBDV, may have been due to behavioural differences that tend to result in their ingesting a relatively low dose of the virus.


Subject(s)
Birnaviridae Infections/veterinary , Chickens , Infectious bursal disease virus/pathogenicity , Poultry Diseases/immunology , Animals , Antibodies, Viral/blood , Antigens, Viral/analysis , Birnaviridae Infections/immunology , Birnaviridae Infections/transmission , Bursa of Fabricius/virology , Disease Susceptibility , Female , Immunodiffusion/veterinary , Infectious bursal disease virus/immunology , Male , Neutralization Tests/veterinary , Nigeria , Poultry Diseases/transmission , Weight Loss
10.
J Virol ; 73(5): 3560-6, 1999 May.
Article in English | MEDLINE | ID: mdl-10196245

ABSTRACT

Rescue of negative-stranded RNA viruses from full-length genomic cDNA clones is an essential technology for genetic analysis of this class of viruses. Using this technology in our studies of measles virus (MV), we found that the efficiency of the measles virus rescue procedure (F. Radecke et al., EMBO J. 14:5773-5784, 1995) could be improved by modifying the procedure in two ways. First, we found that coculture of transfected 293-3-46 cells with a monolayer of Vero cells increased the number of virus-producing cultures about 20-fold. Second, we determined that heat shock treatment increased the average number of transfected cultures that produced virus another two- to threefold. In addition, heat shock increased the number of plaques produced by positive cultures. The effect of heat shock on rescue led us to test the effect on transient expression from an MV minireplicon. Heat shock increased the level of reporter gene expression when either minireplicon DNA or RNA was used regardless of whether complementation was provided by cotransfection with expression plasmids or infection with MV helper virus. In addition, we found that MV minireplicon gene expression could be stimulated by cotransfection with an Hsp72 expression plasmid, indicating that hsp72 likely plays a role in the effect of heat shock.


Subject(s)
DNA, Viral , Gene Expression Regulation, Viral , Heat-Shock Response/physiology , Measles virus/genetics , Animals , Cell Line, Transformed , Chlorocebus aethiops , Genes, Viral , HSP72 Heat-Shock Proteins , HeLa Cells , Heat-Shock Proteins/genetics , Heat-Shock Proteins/metabolism , Humans , Replicon , Vero Cells
11.
J Virol ; 73(2): 1374-81, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9882342

ABSTRACT

The live-attenuated human parainfluenza virus 3 (PIV3) cold-passage 45 (cp45) candidate vaccine was shown previously to be safe, immunogenic, and phenotypically stable in seronegative human infants. Previous findings indicated that each of the three amino acid substitutions in the L polymerase protein of cp45 independently confers the temperature-sensitive (ts) and attenuation (att) phenotypes but not the cold-adaptation (ca) phenotype (29). cp45 contains 12 additional potentially important point mutations in other proteins (N, C, M, F, and hemagglutinin-neuraminidase [HN]) or in cis-acting sequences (the leader region and the transcription gene start [GS] signal of the N gene), and their contribution to these phenotypes was undefined. To further characterize the genetic basis for the ts, ca, and att phenotypes of this promising vaccine candidate, we constructed, using a reverse genetics system, a recombinant cp45 virus that contained all 15 cp45-specific mutations mentioned above, and found that it was essentially indistinguishable from the biologically derived cp45 on the basis of plaque size, level of temperature sensitivity, cold adaptation, level of replication in the upper and lower respiratory tract of hamsters, and ability to protect hamsters from subsequent wild-type PIV3 challenge. We then constructed recombinant viruses containing the cp45 mutations in individual proteins as well as several combinations of mutations. Analysis of these recombinant viruses revealed that multiple cp45 mutations distributed throughout the genome contribute to the ts, ca, and att phenotypes. In addition to the mutations in the L gene, at least one other mutation in the 3' N region (i.e., including the leader, N GS, and N coding changes) contributes to the ts phenotype. A recombinant virus containing all the cp45 mutations except those in L was more ts than cp45, illustrating the complex nature of this phenotype. The ca phenotype of cp45 also is a complex composite phenotype, reflecting contributions of at least three separate genetic elements, namely, mutations within the 3' N region, the L protein, and the C-M-F-HN region. The att phenotype is a composite of both ts and non-ts mutations. Attenuating ts mutations are located in the L protein, and non-ts attenuating mutations are located in the C and F proteins. The presence of multiple ts and non-ts attenuating mutations in cp45 likely contributes to the high level of attenuation and phenotypic stability of this promising vaccine candidate.


Subject(s)
Mutation , Parainfluenza Virus 3, Human/genetics , Viral Vaccines/genetics , Adaptation, Biological , Animals , Cell Line , Cold Temperature , Cricetinae , Humans , Macaca mulatta , Parainfluenza Virus 3, Human/growth & development , Parainfluenza Virus 3, Human/immunology , Phenotype , Vaccines, Attenuated , Viral Plaque Assay , Viral Vaccines/immunology
13.
J Virol ; 72(4): 2905-16, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9525611

ABSTRACT

This paper provides evidence for a measles virus receptor other than CD46 on transformed marmoset and human B cells. We first showed that most tissues of marmosets are missing the SCR1 domain of CD46, which is essential for the binding of Edmonston measles virus, a laboratory strain that has been propagated in Vero monkey kidney cells. In spite of this deletion, the common marmoset was shown to be susceptible to infections by wild-type isolates of measles virus, although they did not support Edmonston measles virus production. As one would expect from these results, measles virus could not be propagated in owl monkey or marmoset kidney cell lines, but surprisingly, both a wild-type isolate (Montefiore 89) and the Edmonston laboratory strain of measles virus grew efficiently in B95-8 marmoset B cells. In addition, antibodies directed against CD46 had no effect on wild-type infections of marmoset B cells and only partially inhibited the replication of the Edmonston laboratory strain in the same cells. A direct binding assay with insect cells expressing the hemagglutinin (H) proteins of either the Edmonston or Montefiore 89 measles virus strains was used to probe the receptors on these B cells. Insect cells expressing Edmonston H but not the wild-type H bound to rodent cells with CD46 on their surface. On the other hand, both the Montefiore 89 H and Edmonston H proteins adhered to marmoset and human B cells. Most wild-type H proteins have asparagine residues at position 481 and can be converted to a CD46-binding phenotype by replacement of the residue with tyrosine. Similarly, the Edmonston H protein did not bind CD46 when its Tyr481 was converted to asparagine. However, this mutation did not affect the ability of Edmonston H to bind marmoset and human B cells. The preceding results provide evidence, through the use of a direct binding assay, that a second receptor for measles virus is present on primate B cells.


Subject(s)
Antigens, CD/metabolism , B-Lymphocytes/metabolism , Hemagglutinins, Viral/metabolism , Measles virus/metabolism , Membrane Glycoproteins/metabolism , Amino Acid Sequence , Animals , Antibodies/immunology , Antigens, CD/genetics , Aotidae , B-Lymphocytes/cytology , Base Sequence , Callithrix , Cell Line , Chlorocebus aethiops , DNA, Complementary , HeLa Cells , Humans , Kidney/cytology , Lung/cytology , Membrane Cofactor Protein , Membrane Glycoproteins/genetics , Molecular Sequence Data , Saimiri , Sequence Deletion , Vero Cells
14.
J Virol ; 71(11): 8531-41, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9343211

ABSTRACT

Six female rhesus macaques were immunized orally and intranasally at 0 weeks and intratracheally at 12 weeks with an adenovirus type 5 host range mutant (Ad5hr)-simian immunodeficiency virus SIVsm env recombinant and at 24 and 36 weeks with native SIVmac251 gp120 in Syntex adjuvant. Four macaques received the Ad5hr vector and adjuvant alone; two additional controls were naive. In vivo replication of the Ad5hr wild-type and recombinant vectors occurred with detection of Ad5 DNA in stool samples and/or nasal secretions in all macaques and increases in Ad5 neutralizing antibody in 9 of 10 macaques following Ad administrations. SIV-specific neutralizing antibodies appeared after the second recombinant immunization and rose to titers > 10,000 following the second subunit boost. Immunoglobulin G (IgG) and IgA antibodies able to bind gp120 developed in nasal and rectal secretions, and SIV-specific IgGs were also observed in vaginal secretions and saliva. T-cell proliferative responses to SIV gp140 and T-helper epitopes were sporadically detected in all immunized macaques. Following vaginal challenge with SIVmac251, transient or persistent infection resulted in both immunized and control monkeys. The mean viral burden in persistently infected immunized macaques was significantly decreased in the primary infection period compared to that of control macaques. These results establish in vivo use of the Ad5hr vector, which overcomes the host range restriction of human Ads for rhesus macaques, thereby providing a new model for evaluation of Ad-based vaccines. In addition, they show that a vaccine regimen using the Ad5hr-SIV env recombinant and gp120 subunit induces strong humoral, cellular, and mucosal immunity in rhesus macaques. The reduced viral burden achieved solely with an env-based vaccine supports further development of Ad-based vaccines comprising additional viral components for immune therapy and AIDS vaccine development.


Subject(s)
Adenoviruses, Human/immunology , Genes, env , SAIDS Vaccines/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/immunology , Viral Vaccines/immunology , Amino Acid Sequence , Animals , Antibodies, Viral/biosynthesis , Antibody Formation , Antigens, Viral/immunology , Female , Immunity, Cellular , Immunity, Mucosal , Immunoglobulin G/immunology , Lymphocyte Activation , Macaca mulatta , Molecular Sequence Data , Peptide Fragments/immunology , Vaccines, Synthetic , Vagina/immunology , Virus Replication
15.
Proc Natl Acad Sci U S A ; 94(25): 13961-6, 1997 Dec 09.
Article in English | MEDLINE | ID: mdl-9391135

ABSTRACT

A live, cold-passaged (cp) candidate vaccine virus, designated respiratory syncytial virus (RSV) B1 cp-52/2B5 (cp-52), replicated efficiently in Vero cells, but was found to be overattenuated for RSV-seronegative infants and children. Sequence analysis of reverse-transcription-PCR-amplified fragments of this mutant revealed a large deletion spanning most of the coding sequences for the small hydrophobic (SH) and attachment (G) proteins. Northern blot analysis of cp-52 detected multiple unique read-through mRNAs containing SH and G sequences, consistent with a deletion mutation spanning the SH:G gene junction. Immunological studies confirmed that an intact G glycoprotein was not produced by the cp-52 virus. Nonetheless, cp-52 was infectious and replicated to high titer in tissue culture despite the absence of the viral surface SH and G glycoproteins. Thus, our characterization of this negative-strand RNA virus identified a novel replication-competent deletion mutant lacking two of its three surface glycoproteins. The requirement of SH and G for efficient replication in vivo suggests that selective deletion of one or both of these RSV genes may provide an alternative or additive strategy for developing an optimally attenuated vaccine candidate.


Subject(s)
HN Protein , Mutation , Respiratory Syncytial Virus, Human/genetics , Respiratory Syncytial Virus, Human/physiology , Viral Proteins/genetics , Viral Proteins/physiology , Animals , Child , Chlorocebus aethiops , Chromosome Mapping , Gene Deletion , Genes, Viral , Humans , Infant , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Syncytial Virus, Human/pathogenicity , Vaccines, Attenuated/genetics , Vaccines, Synthetic/genetics , Vero Cells , Viral Envelope Proteins , Viral Proteins/immunology , Viral Vaccines/genetics , Virulence/genetics , Virus Replication/genetics
16.
J Virol ; 69(4): 2480-5, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7884896

ABSTRACT

Subacute sclerosing panencephalitis is a slowly progressing fatal human disease of the central nervous system which is a delayed sequel of measles virus (MV) infection. A typical pathological feature of this disease is the presence of viral ribonucleocapsid structures in the form of inclusion bodies and the absence of infectious virus or budding viral particles. The mechanisms governing the establishment and maintenance of a persistent MV infection in brain cells are still largely unknown. To understand the mechanisms underlying MV persistence in neuronal cells, a tissue culture model was studied. Clone NS20Y/MS of the murine neuroblastoma C1300 persistently infected with the wild-type Edmonston strain of MV secretes relatively high levels of alpha/beta interferon (IFN). As shown previously, treatment of the persistently infected cultures with anti-IFN serum converted the persistent state into a productive infection indicated by the appearance of multinucleated giant cells. In this study, we have investigated whether alpha/beta IFN produced by NS20Y/MS cells activates cellular protein tyrosine kinases which will induce tyrosine phosphorylating activity specific to virus-infected cells. We present data to show augmented protein tyrosine kinase activity in the persistently infected cells. We demonstrate that the MV N protein is phosphorylated on tyrosine in addition to serine and threonine in the persistent state but not in NS20Y cells acutely infected with MV.


Subject(s)
Capsid/metabolism , Measles virus/metabolism , Nucleoproteins/metabolism , Tyrosine/metabolism , Viral Proteins/metabolism , 2',5'-Oligoadenylate Synthetase/metabolism , Humans , Neuroblastoma/virology , Nucleocapsid Proteins , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Serine/metabolism , Threonine/metabolism , Tumor Cells, Cultured , eIF-2 Kinase
17.
Virology ; 208(2): 800-7, 1995 Apr 20.
Article in English | MEDLINE | ID: mdl-7747454

ABSTRACT

Measles virus (MV) mRNA transcription and replication are thought to be controlled by cis-acting sequence elements contained within the terminal MV genomic noncoding nucleotides. To validate these promoter and regulatory signal assignments, cDNAs were constructed allowing synthesis of RNAs corresponding to a MV genome in which all coding and intercistronic regions were replaced by the chloramphenicol acetyl transferase (CAT) coding sequence. Transcript production by T7 polymerase starting and ending precisely with the MV genome terminal residues was achieved by fusing the T7 polymerase promoter and the hepatitis delta virus genome ribozyme followed by tandem T7 polymerase termination sequences to the MV genomic 5' and 3' ends, respectively. Transfection of these negative polarity transcripts, mimicking natural defective interfering RNAs of the internal deletion type, into MV-infected 293 cells gave rise to CAT activity which could be serially transferred and massively amplified together with progeny helper virus in fresh cells. Transfer was blocked only by antibodies able to neutralize MV infectivity, indicating that the chimeric RNA not only was encapsidated, transcribed, and replicated, but also packaged into virions. Sequence analyses confirmed that both the expected chimeric antigenome and mRNA products were transcribed and replicated with fidelity during serial passage. Minor changes introduced in the transcription promoter markedly compromised function. This system now can be exploited to examine MV genomic cis-acting regulatory elements and extended to the development of full-length MV cDNAs.


Subject(s)
Gene Expression Regulation, Viral/genetics , Measles virus/genetics , Promoter Regions, Genetic/genetics , Replicon/genetics , Transcription, Genetic/genetics , Base Sequence , Cell Line , Chloramphenicol O-Acetyltransferase/biosynthesis , Chloramphenicol O-Acetyltransferase/genetics , Genes, Reporter/genetics , Genome, Viral , Helper Viruses/physiology , Measles virus/physiology , Molecular Sequence Data , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Viral/biosynthesis , RNA, Viral/genetics , Recombinant Fusion Proteins/biosynthesis , Serial Passage , Transfection , Virus Replication/genetics
18.
Virology ; 202(2): 631-41, 1994 Aug 01.
Article in English | MEDLINE | ID: mdl-8030228

ABSTRACT

Evidence is presented showing that the brain cells of patients with subacute sclerosing panencephalitis (SSPE) contain mutant measles (MV) genomes having the characteristics of 5' copy-back defective interfering (DI) RNAs. Using a polymerase chain reaction-based amplification specific for copy-back DIs, abundant, discrete cDNAs representing different-sized MV defective RNA species were generated from each SSPE brain. The defective genomes were cloned in two portions. The most common of these defective species were sequenced, confirming their MV genome origin and 5' copy-back nature. We deduced that the minimum DI stem length of these species was 95 nucleotides, further delimiting the prerequisite 5' regulatory region sequences specifying MV genomic replication/encapsidation functions. This calculation assumes a precise copy-back mechanism and complete complementarity of the panhandle structure. Since the SSPE-derived viral genome encodes dysfunctional viral envelope proteins, we hypothesize that SSPE brains may lack the high degree of selective pressure encountered in tissue culture MV infections. This allows for the coexistence of numerous replication-competent defective particles in each SSPE brain. A role for viral defective particles as modulators of this persistent measles virus infection of humans is proposed.


Subject(s)
Brain/microbiology , Defective Viruses/genetics , Measles virus/pathogenicity , RNA, Viral/genetics , Subacute Sclerosing Panencephalitis/microbiology , Base Sequence , Cloning, Molecular , DNA Primers/chemistry , Humans , In Situ Hybridization , Measles Vaccine/genetics , Measles virus/genetics , Molecular Sequence Data , RNA, Messenger/genetics
19.
J Nucl Med ; 35(6): 1028-34, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8195863

ABSTRACT

UNLABELLED: The diagnosis of Pneumocystis carinii pneumonia (PCP) currently relies upon cytological demonstration of the organism in sputum or bronchoscopy specimens. The purpose of this study was to develop a radiolabeled monoclonal antibody (Mab) against Pneumocystis carinii (P. carinii) and to evaluate its use for imaging PCP. METHODS: We studied 16 HIV-infected patients with pneumonia in order to evaluate a new Mab-based imaging method for diagnosing PCP. Most patients were managed for opportunistic pneumonia associated with AIDS, including standard cytological tests, and, in all cases, intensive chemotherapy. Prior to the clinical study, the Mab raised to P. carinii was shown to react with human P. carinii but not with rat P. carinii or human white blood cells. RESULTS: After labeling a 1-mg Mab Fab' fragment with 30 mCi of 99mTc, the presence or absence of PCP could be confirmed in six of seven or seven of eight assessable patients, respectively, by external photoscanning within 24 hr. This shows a sensitivity of 85.7% and a specificity of 86.7%. CONCLUSION: Our findings suggest that PCP can be diagnosed by a noninvasive imaging method employing a small dose of a 99mTc-labeled Mab showing specificity for the infectious organism, since patients with P. carinii-free pneumonia were correctly negative in 87.5% of cases. Rapid diagnosis and organ-localization of other infectious lesions with organism-specific, radiolabeled Mabs may be feasible.


Subject(s)
AIDS-Related Opportunistic Infections/diagnostic imaging , Pneumonia, Pneumocystis/diagnostic imaging , Radioimmunodetection , Adult , Antibodies, Monoclonal , Female , Humans , Iodine Radioisotopes , Lung/diagnostic imaging , Male , Radiography , Technetium
20.
J Gen Virol ; 75 ( Pt 4): 819-27, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8151298

ABSTRACT

To investigate the effect of persistent measles virus infection on signal transduction in cells of neuronal origin, the mouse neuroblastoma cell line NS20Y/MS, which is persistently infected with measles virus, was used. The results demonstrate an approximate 50% increase in total phosphorylation and a similar increase in protein kinase C (PKC) activity. Western blot analysis with anti-total PKC or anti-PKC-alpha antibodies revealed a significant increase in the level of an 80K immunoreactive PKC in NS20Y/MS cells. Following incubation of NS20Y/MS cells with polyclonal anti-measles virus antibodies, which down-regulate the level of measles virus proteins, total and PKC-mediated phosphorylation returned to the basal level of uninfected cells. This effect was reversible and removal of the antibodies resulted in restoration of the high level of total and PKC-mediated phosphorylation. The release of infectious measles virus was strongly inhibited by incubation of NS20Y/MS cells with the PKC inhibitor, 1-(5-isoquinolinylsulphonyl)-2-methylpiperazine (H-7). These results demonstrate that measles virus induces elevation in cellular phosphorylation which is essential for measles virus production.


Subject(s)
Antibodies, Viral/immunology , Measles virus/physiology , Protein Kinase C/metabolism , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine , Animals , Antibodies, Monoclonal/immunology , Cytosol/chemistry , Down-Regulation/drug effects , Immune Sera , Isoquinolines/pharmacology , Measles virus/immunology , Membrane Proteins/analysis , Mice , Neutralization Tests , Phosphorylation/drug effects , Piperazines/pharmacology , Protein Kinase C/analysis , Protein Kinase C/antagonists & inhibitors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...